Drug intelligence / Profile preview

QuickStrip Medical Cannabis

Development stage
Unknown
Lead developer
Rapid Dose Therapeutics
Modality
Small Molecules
Administration
Sublingual, Buccal
01

Overview

QuickStrip Medical Cannabis is an oral thin film drug delivery platform developed by Rapid Dose Therapeutics. It utilizes a proprietary fast-dissolving strip technology to deliver micronized cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD), through the sublingual or buccal mucosa. This delivery method allows the active ingredients to enter the bloodstream directly, bypassing the gastrointestinal tract and first-pass metabolism in the liver, which results in a more rapid onset of action compared to traditional oral ingestion. The product is designed to alleviate symptoms associated with chronic pain, anxiety, sleep disorders, and various neurological conditions. It has received regulatory approval from ANVISA in Brazil and is licensed for the medical cannabis market in Canada.

Brand names
QuickStripPharmaStrip
Other names
QuickStrip™ Medical Cannabis
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on QuickStrip Medical Cannabis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on QuickStrip Medical Cannabis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call